閾剁墝浼氬憳绗?span style="font-size:1.5em;color:#f21">2骞滁/div> 璁块棶閲廁 3596427 缃戝潃:vbogene.cnreagent.com 鍦ㄧ嚎鐣欒█
浜у搧鎼滅储
铔嬬櫧璐?鎶楀師/澶氳偨 >> 閲嶇粍铔嬬櫧
閲嶇粍CMBL铔嬬櫧
閲嶇粍CMBL铔嬬櫧鍥剧墖
浜よ揣鏈烔 1鍛?/span>
绱㈠彇璧勬枡鍙婃姤浠饵/span>
浜よ揣鏈烔 1鍛?/td>
浜у搧鍒悕: Recombinant Cmbl
Recombinant carboxymethylenebutenolidase-like (Pseudomonas) protein
浜у搧浠嬬粛
鍩哄洜鍚嶏細

Cmbl


浜у搧鍒悕锛欬p style="text-indent: 2em;">2310016A09Rik锛 Cmbl锛 carboxymethylenebutenolidase-like (Pseudomonas)锛 carboxymethylenebutenolidase-like (Pseudomonas)锛 carboxymethylenebutenolidase homolog锛 CMBL铔嬬櫧锛


鑳屾櫙淇℃伅锛欬div style="text-indent: 2em;">CMBL is a 245 amino acid cytosolic protein and cysteine hydrolase that preferentially cleaves cyclic esters. A member of the dienelactone hydrolase family, CMBL is the human homolog of Pseudomonas dienelactone hydrolase, a protein that participates in the bacterial halocatechol degradation pathway. CMBL is ubiquitously expressed with high expression in liver, colon, kidney and small intestine, where it acts as a bioactivating enzyme for a prodrug type angiotensin II type 1 receptor antagonist known as olmesartan medoxomil. CMBL is inhibited by p-chloromercuribenzoate (PCMB) and is encoded by a gene that maps to human chromosome 5p15.2. Chromosome 5 contains 181 million base pairs and comprises nearly 6% of the human genome. Deletion of the p arm of chromosome 5 leads to Cri du chat syndrome, while deletion of the q arm, or of chromosome 5 altogether, is common in therapy-related acute myelogenous leukemias and myelodysplastic syndrome.

鏍囩锛欻is-tag
鍒嗙被锛歊ecombinant
绫诲瀷锛歅rotein
鍋惰仈鐗╋細Unconjugated
鍐呮瘨绱犳按骞筹細鎸夋壒娆★紝鍙傞槄鐡惰韩鏍囩
鎬х姸:Liquid
娴撳害锛欱atch dependent (Please refer to the vial label for the specific concentration.)
绾寲绫诲瀷锛歱urified
鍐呭惈鐗╋細涓嶅惈闃茶厫鍓侟br/>搴旂敤:Positive Control;Immunogen;SDS-PAGE;WB.
鍌ㄥ瓨锛?-8掳C涓嶈秴杩囦竴涓湀锛?80掳C涓嶈秴杩?2涓湀銆傞伩鍏嶅弽澶嶅喕铻嶃€侟br/>娉ㄦ剰浜嬮」锛氫粎渚涘疄楠屽浣跨敤銆備笉閫傜敤浜庝汉绫绘垨鍔ㄧ墿鐨勪换浣曚复搴婏紝娌荤枟鎴栬瘖鏂敤閫斻€備笉閫傚悎鍔ㄧ墿鎴栦汉绫婚鐢ㄣ€侟/p>

鐩稿叧浜у搧
Baidu
map